Clinical Trial Update: Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure [NA]

View source ↗

Summary

Clinical trial comparing Ripertamab plus eltrombopag versus eltrombopag alone in patients with immune thrombocytopenia after failure of steroids; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• Ripertamab

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: ITP - Immune Thrombocytopenia | NA | Status: NOT_YET_RECRUITING